January 28th, 2021Longevity Biotech to Participate in Longevity Therapeutics ConferenceLongevity Biotech CEO, Dr. Scott Shandler, Ph.D., will participate in the 3rd annual Longevity Therapeutics Conference held on January 27-28th, 2021. Dr. Shandler will participate in … Read More
Biomarkers for AD Conference
Longevity Biotech CEO Scott Shandler to share precision neuroscience insights and lessons learned from recent Parkinson’s Disease biomarker study.
Longevity Biotech Initiates Clinical Neuroinflammation Biomarker Study
July 16, 2018 Longevity Biotech, Inc. Initiates Clinical Neuroinflammation Biomarker Study at the Department of Veterans Affairs to Investigate Immune-related Aspects of Parkinson’s Disease with Continued Support from The Michael J. Fox Foundation Philadelphia, … Read More